Abstract A 2A adenosine receptors are considered an excellent target for drug development in several neurological and psychiatric disorders. It is noteworthy that the responses evoked by A 2A adenosine receptors are regulated by D 2 dopamine receptor ligands. These two receptors are coexpressed at the level of the basal ganglia and interact to form functional heterodimers. In this context, possible changes in A 2A adenosine receptor functional responses caused by the chronic blockade/activation of D 2 dopamine receptors should be considered to optimise the therapeutic effectiveness of dopaminergic agents and to reduce any possible side effects. In the present paper, we investigated the regulation of A 2A adenosine receptors induced by antipsychotic drugs, commonly acting as D 2 dopamine receptor antagonists, in a cellular model co-expressing both A 2A and D 2 receptors. Our data suggest that the treatment of cells with the classical antipsychotic haloperidol increased both the affinity and responsiveness of the A 2A receptor and also affected the degree of A 2A -D 2 receptor heterodimerisation. In contrast, an atypical antipsychotic, clozapine, had no effect on A 2A adenosine receptor parameters, suggesting that the two classes of drugs have different effects on adenosinedopamine receptor interaction. Modifications to A 2A adenosine receptors may play a significant role in determining cerebral adenosine effects during the chronic administration of antipsychotics in psychiatric diseases and may account for the efficacy of A 2A adenosine receptor ligands in pathologies associated with dopaminergic system dysfunction.
Introduction
The endogenous neuromodulator adenosine controls and integrates a wide range of brain functions [1] and is involved in the etiopathogenesis of several pathologies ranging from epilepsy to neurodegenerative disorders and psychiatric conditions. The adenosine system has thus been recognised as a prime target for the development of new therapeutics to treat these diseases.
From epidemiological to animal studies, it is clear that extracellular adenosine acting at adenosine receptors (ARs) influences the functional outcome of a broad spectrum of brain injuries. In the brain, A 2A ARs are mainly expressed at the level of neurons, glial cells [2] [3] [4] [5] [6] [7] and peripheral inflammatory M. Letizia Trincavelli and S. Cuboni equally contributed to the study.
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The online version of this article (doi:10.1007/s11302-010-9201-z) contains supplementary material, which is available to authorized users. cells, playing a role in both neuroprotection and neurodegeneration [8] [9] [10] . The alterations in A 2A AR density and functional responsiveness that occurred during pathological conditions (i.e. neurological and psychiatric diseases) represent a crucial aspect in the balance between the protective and toxic effects exerted by this receptor subtype at the central level. Using a rat model of focal ischaemia, it has been demonstrated that increases in A 2A AR density may contribute to A 2A AR-mediated neuron death [11] . In addition, an increase in A 2A AR density and/or functionality has also been detected in psychiatric diseases such as schizophrenia [12] and bipolar disorders [13] : in these pathologies, alterations in A 2A AR parameters have been related to the chronic use of antipsychotic drugs, D 2 dopamine receptor (DR) antagonists [14] [15] [16] , and also the functional crosstalk between the adenosine and dopamine systems.
In recent years, it has been indicated that adenosine and dopamine interact functionally in the brain and that this structural association may have pathophysiological and therapeutic implications [17] [18] [19] . In the corpus striatum and mesolimbic areas, where the two receptors mostly co-localise [20] , it has been demonstrated that they are structurally associated to form functional heterodimers in which the adenosine and dopamine receptors mutually antagonise their respective responses [21] [22] [23] [24] [25] . On the basis of these results, A 2A AR agonists have been suggested as possible drugs, in association with antipsychotics, for the treatment of psychotic symptoms in schizophrenia and bipolar disorders [26, 27] .
Investigation of the molecular mechanisms involved in the crosstalk between A 2A ARs and D 2 DRs and the effects of antipsychotic drugs on A 2A AR modulation may represent a crucial starting point to (1) clarify the role of the adenosine system in several psychiatric disorders; (2) optimise antipsychotic therapy; and (3) reduce the possible side effects inherent in hyperactivity of the adenosine system induced by the chronic administration of antipsychotic drugs, such as extrapyramidal symptoms.
For this purpose, we established a cellular model in which these receptors are stably co-expressed at high levels, and we investigated the effects of D 2 DR antagonists (haloperidol and clozapine) on A 2A AR binding parameters and functional responsiveness. The availability of this cellular model allowed us to overcome the problem of recovering biological samples from patients in quantities sufficient for biochemical analysis.
Materials and methods

Calcium phosphate transfection of D 2L receptor in CHO cells
Cell lines co-expressing A 2A ARs and D 2 DRs were obtained by calcium phosphate transfection. A solution of 100 μl of 2.5 M CaCl 2 and 10 μg of plasmid pcDNA3.1/Hygro(+) containing human D 2L (long-form) DR was diluted 1/10 in TE buffer (1 mM Tris-HCl, 0.1 mM EDTA, pH 7.6) to a final volume of 500 μl. One volume of this 2x Ca H /DNA solution was added quickly to an equal volume of 2X HEPES solution (140 mM NaCl, 1.5 mM Na 2 HPO 4 , 50 mM HEPES, pH 7.05 at 23°C). The two solutions were mixed quickly and added dropwise to Chinese hamster ovary (CHO) cells stably transfected with A 2A AR [28] . After 1 day, the plates were washed twice with NaCl 0.9% and new medium without antibiotics was added. The following day, 0.5 mg/ml Hygromycin was added to the media to initiate selection for stably transfected cells. Selection continued with periodic treatment of cells with different concentrations of antibiotic to a final concentration of 0.2 mg/ml.
Cell culture CHO cells stably transfected with human A 2A ARs and D 2L DRs were grown adherently and were maintained in Dulbecco's modified Eagle's medium with nutrient mixture F12 (DMEM/F12) containing 10% foetal bovine serum (FBS), penicillin (200 U/ml), streptomycin (200 μg/ml), and L-glutamine (4 mM) at 37°C, 5% CO 2 and 95% humidity.
Cell treatments CHO cells co-transfected with A 2A ARs and D 2 DRs were plated using complete media supplemented with 0.2 mg/ml Hygromycin and 0.2 mg/ml Geneticin (G418) in order to maintain selection pressure for D 2 DR and A 2A AR, respectively. After 48 h, cells were treated for 1-24 h with 1 nM-10 μM of the antipsychotic haloperidol or clozapine under serum-deprived conditions using DMEM/F12 supplemented with 1% FBS. At the end of the treatments, membrane fractions were prepared and protein concentrations were detected according to the Bio-Rad method [29] using bovine albumin as a reference standard. Control and treated cells were used for A 2A AR binding and functional assays. H]YM 09151-2) concentrations. Nonspecific binding was determined in the presence of 1.5 mM dopamine. The cells were incubated for 1 h at 30°C, and the binding reaction was terminated by rapid filtration under vacuum through Whatman GF/C glass fibre filters (Millipore Corporation) pretreated with 0.6% polyethylenimine. The filters were washed three times with 4 ml of filtration buffer (10 mM Tris-HCl, 155 mM NaCl, pH 7.4) and then counted in 4 ml of scintillation cocktail.
A 2A AR binding assay Cells were washed twice with cold PBS (9.1 mM NaH 2 PO 4 , 1.7 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.4) and detached with lysis buffer (50 mM Tris-HCl, 2 mM EDTA, pH 7.4). Cells were harvested, homogenised and centrifuged at 48,000×g for 20 min at 4°C before the pellet was suspended in binding buffer (50 mM Tris-HCl, 2 mM MgCl 2 , pH 7.4).
Competitive binding assays (cold analysis) were performed by incubating 30 μg of CHO membranes with 2 U/ml adenosine deaminase (ADA) in 0.5 ml of binding buffer containing 10 nM of the AR agonist [ Immunocomplexes, after being washed, were resuspended in Laemmli solution and boiled for 5 min and were then resolved by SDS-PAGE (10%), transferred to nitrocellulose membranes and probed overnight at 4°C with primary antibody anti-A 2A AR (1:500). Membranes, after incubation with the secondary antibody, were developed using Millipore chemioluminescent reagents. The specificity of A 2A AR immunoreactive bands were evaluated using wildtype CHO cells as a negative control.
AC activity at A 2A AR Cells were washed twice with cold PBS and detached with ice-cold hypotonic buffer (5 mM Tris, 2 mM EDTA, pH 7.4). The cell suspension was homogenised on ice (Ultra-Turrax, 2×15 s at full speed) and the homogenate was centrifuged for 10 min at 1,000×g at 4°C. The supernatant was then centrifuged for 45 min at 100,000×g, and the membrane pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.4, and immediately used in functional assays.
The potency of the agonist NECA against A 2A AR was determined by assessing the ability of increasing agonist concentrations to stimulate cAMP accumulation. The procedure was carried out as previously described [30] , with minor modifications. A total volume of 100 μl of incubation medium contained 50 mM Tris-HCl, pH 7.4, approximately 200,000 cpm of [α-32 P]ATP, 100 μM unlabeled ATP, 10 μM GTP, 100 μM cyclic AMP, 1 mM MgCl 2 , 500 μM Ro 20-1724, 0.4 mg/ml creatine kinase, 5 mM creatine phosphate, 2 mg/ml bovine serum albumin and 0.2 U/ml ADA.
Data analysis
For data analysis and graphic presentation, the nonlinear multipurpose curve fitting computer programme Graph-Pad Prism (GraphPad, San Diego, CA) was used. For saturation and competition binding studies, Scatchard analysis was performed, whilst sigmoidal dose-response curve fitting was used for functional data. Statistical analyses of binding and functional data (expressed as means ± SEM) were performed using Student's t test. Results were considered significant at P<0.05. (Fig. 3a) . These values were not significantly different from those obtained in control cells (10% serum, P>0.05), suggesting that serum limitation did not affect A 2A AR binding parameters in CHO cells.
Results
Cells were treated for 24 h with the classical and atypical antipsychotics haloperidol and clozapine at different concentrations (ranging from 1 nM to 10 μM), and then [ 3 H] NECA-specific binding to A 2A ARs was evaluated. The results (Fig. 2) Fig. 3a) . Treatment with 1 μM clozapine (Fig. 3b) In control cells, NECA activated AC with an EC 50 value of 5.09±0.67 nM (Fig. 4a ). After treatment with 1 μM haloperidol (Fig. 4b) , a significant increase in A 2A AR responsiveness compared to the control was observed (haloperidol: EC 50 =3.64±0.57 nM, P<0.01 vs. control cells). Cells treated with 1 μM clozapine (Fig. 4c) These results suggest that during chronic treatment with classical antipsychotic drugs, A 2A AR underwent subtle regulatory changes affecting its receptor binding properties and functional responsiveness. These receptor changes represent a crucial aspect in further clarifying the pathophysiological role of adenosine in psychiatric diseases and should be taken into account (1) in developing new drugs as well as (2) in preventing possible side effects of drugs indirectly modulating the adenosine system. In our specific context, the underlying regulation of A 2A AR during antipsychotic administration represents an important target for the optimisation of pharmacological therapy in pathologies associated with psychotic symptoms.
To investigate this issue, we developed a CHO cell line that stably co-expressed both A 2A and D 2 receptors at high levels. In this clone, a monomeric form of A 2A AR [32] In parallel, we demonstrated that the atypical antipsychotic clozapine did not have any effect on A 2A AR binding and functional parameters. Despite their common therapeutic usage, the differences in A 2A AR regulation induced by these two classes of antipsychotics confirmed that these drugs have different mechanisms of action at the molecular level. Indeed, a crucial point that distinguishes antipsychotics is the degree of dopamine D 2 DR occupancy and the kinetics of drug-receptor dissociation, on which the drug response and some unpleasant side effects depend. Classical antipsychotics, such as haloper- idol, have high D 2 DR occupancy and slow dissociation rates compared to atypical antipsychotics [33] ; occupancy increases above 80% and is connected with increased extrapyramidal side effects, elevation of prolactin levels [34, 35] and dyskinesias. Clozapine, an atypical drug, shows a much lower occupancy (16%-68%) and a fast dissociation rate; this may explain its lack of extrapyramidal side effects and prolactin elevation [36, 37] . These differences in D 2 DR occupancy were confirmed in our experimental conditions. In fact, we showed that following treatment with haloperidol for 24 h and the subsequent washing of the cells, only 59% of D 2 DR binding sites are labelled by the D 2 DR antagonist [
3 H]YM 09151-2. These results could be explained by supposing that (1) the drug remained bound to the receptor, causing receptor occupancy of about 41%, and (2) the long time block of D 2 DR by the antagonist, haloperidol, caused receptor down-regulation. Only in "in vivo" experiments has it been demonstrated that the chronic administration of haloperidol to rats for 14 days or 8 months induced dysregulation of D 2 DR expression levels in different brain regions [38, 39] . Otherwise, in striatal and astroglial cell cultures, treatment with antipsychotics for 12 h is not enough to induce changes in D 2 DR expression levels [40] . These data lead us to speculate that the effects of 24-h haloperidol treatment on D 2 DR binding in CHO cells are presumably due to receptor occupation rather than to receptor down-regulation.
Clozapine is completely removed from D 2 DR binding sites and did not affect D 2 DR-specific binding, probably as a consequence of its rapid dissociation constant. These differences in D 2 receptor occupancy may be at the root of specific effects observed in A 2A AR regulatory mechanisms, and it is possible to speculate that the degree of D 2 DR occupancy is important in the regulation of A 2A AR responses. This hypothesis might also be supported by data obtained in immunoprecipitation experiments demonstrating that only haloperidol, but not clozapine, was able to increase A 2A /D 2 heteromeric association. Further studies are in progress to investigate the role of this heteromeric association in the control of A 2A receptor responsiveness induced by antipsychotics.
The main conclusion of this study is that blockade of D 2 DRs induced changes in A 2A AR responses, confirming the existence of functional crosstalk between the adenosine and dopamine systems. As a consequence, the hyperresponsiveness of A 2A ARs, induced by haloperidol treatment, could justify the proposed use of A 2A AR agonists in association with classical antipsychotic therapy [17, 26, 27, 41, 42] in several psychiatric diseases associated with a dopamine system hyperactivity.
On the other hand, one should not forget the neurodegererative and toxic effects that A 2A ARs exert at the central level [43] [44] [45] [46] [47] [48] [49] . In this context, A 2A AR hyperactivity may have important pathophysiological implications and might contribute to, induce or exacerbate neurodegenerative effects in several psychiatric diseases. In this scenario, the choice of the antipsychotic, and particularly its dosage, should always follow an investigation of the individual's proneness to other diseases.
